Table 4. Comparison of cardiac function between baseline and 12 weeks.
Control group | Exercise group | |||
---|---|---|---|---|
Baseline | 12 weeks | Baseline | 12 weeks | |
SBP (mmHg) | 145±21 | 149±19 | 142±18 | 129±16*∆ |
DBP (mmHg) | 89±12 | 92±11 | 88±13 | 80±10*∆ |
HR (bpm) | 72±11 | 73±12 | 74±10 | 65±8*∆ |
LVEF (%) | 56.3±13.9 | 57.1±12.2 | 56.5±12.3 | 63.5±10.7*∆ |
LVDD (mm) | 44.0±6.0 | 43.9±6.9 | 44.2±6.6 | 43.8±4.7 |
LVSD (mm) | 31.9±5.7 | 32.5±4.5 | 32.4±4.4 | 31.2±3.8 |
*p<0.05 compared with the value at baseline, by the Wilcoxon’s test. ∆p<0.05 compared with the value in control group, by the Mann-Whitney U test. DBP, diastolic blood pressure; HR, heart rate; LVDD, left ventricular diastolic diameter; LVEF, left ventricular ejection fraction; LVSD, left ventricular systolic diameter; SBP, systolic blood pressure